TLR9-independent activation of B lymphocytes by bacterial DNA
- PMID: 16716115
- DOI: 10.1089/dna.2006.25.253
TLR9-independent activation of B lymphocytes by bacterial DNA
Abstract
The intracellular Toll-like receptor 9 (TLR9) is unique in its ability to recognize single-stranded DNA unmethylated at CpG motifs. Work from this laboratory showed that plasmid DNA is spontaneously internalized in B lymphocytes. This event is followed by the upregulation of costimulatory molecules and the acquisition of antigen presenting function by these cells. However, it is not known whether this phenomenon depends on TLR9. Because of the relevant role played by DNA-based drugs in immunotherapy and vaccination, and the central role of TLR9 signaling by CpG motifs, we decided to investigate whether signaling through TLR9 is a prerequisite for spontaneous transgenesis of lymphocytes. Here we found that transgene expression and upregulation of CD40 and CD86 costimulatory molecules was not inhibited by chloroquine treatment. Spontaneous transgenesis also occurred in B lymphocytes from TLR9-/- mice, and the injection of TLR9-/- transgenic B lymphocytes in C57Bl/6 mice induced both CD4 and CD8 T cell responses comparable to those induced by wild-type B lymphocytes. Collectively, these results suggest that plasmid DNA activates mammalian B lymphocytes through a TLR9 independent pathway.
Similar articles
-
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.J Immunol. 2010 May 15;184(10):5645-53. doi: 10.4049/jimmunol.0901814. Epub 2010 Apr 14. J Immunol. 2010. PMID: 20393135
-
Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.Vaccine. 2007 Aug 21;25(34):6341-7. doi: 10.1016/j.vaccine.2007.06.016. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17628235
-
Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.Eur J Immunol. 2006 Jul;36(7):1951-62. doi: 10.1002/eji.200535734. Eur J Immunol. 2006. PMID: 16791898
-
TLR9 as a key receptor for the recognition of DNA.Adv Drug Deliv Rev. 2008 Apr 29;60(7):795-804. doi: 10.1016/j.addr.2007.12.004. Epub 2008 Jan 3. Adv Drug Deliv Rev. 2008. PMID: 18262306 Review.
-
Role of immunostimulatory DNA and TLR9 in gene therapy.Crit Rev Ther Drug Carrier Syst. 2006;23(2):89-110. doi: 10.1615/critrevtherdrugcarriersyst.v23.i2.10. Crit Rev Ther Drug Carrier Syst. 2006. PMID: 16952273 Review.
Cited by
-
Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection.J Immunol. 2010 Jun 15;184(12):7100-7. doi: 10.4049/jimmunol.0803935. Epub 2010 May 7. J Immunol. 2010. PMID: 20483769 Free PMC article.
-
Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Mediators Inflamm. 2010;2010:986596. doi: 10.1155/2010/986596. Epub 2010 May 18. Mediators Inflamm. 2010. PMID: 20490286 Free PMC article. Review.
-
Modified Genomic Self-DNA Influences In Vitro Survival of HT29 Tumor Cells via TLR9- and Autophagy Signaling.Pathol Oncol Res. 2019 Oct;25(4):1505-1517. doi: 10.1007/s12253-018-0544-z. Epub 2018 Nov 21. Pathol Oncol Res. 2019. PMID: 30465163
-
Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.Infect Immun. 2007 May;75(5):2572-9. doi: 10.1128/IAI.01662-06. Epub 2007 Feb 26. Infect Immun. 2007. PMID: 17325049 Free PMC article.
-
Protein kinase D1: a new component in TLR9 signaling.J Immunol. 2008 Aug 1;181(3):2044-55. doi: 10.4049/jimmunol.181.3.2044. J Immunol. 2008. PMID: 18641342 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
